Log In
BCIQ
Print this Print this
 

svH1D

  Manage Alerts
Collapse Summary General Information
Company Susavion Biosciences Inc.
DescriptionPeptide targeting I-type lectins
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationViral infection
Indication DetailsTreat viral infections
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today